Essa Pharma (EPIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-2007 | 09-2006 | 09-2005 | 09-2004 | 09-2002 | |
| Sales | 14,960 | 6,041 | 7,190 | 12,259 | 12,270 |
| Gross Profit | 14,960 | 6,041 | 7,190 | 12,259 | 12,270 |
| Operating Expenses | 20,997 | 13,954 | 10,656 | 11,427 | 6,001 |
| Operating Income | -6,037 | -7,913 | -3,466 | 832 | 6,268 |
| Interest Expense | 4,068 | 5,076 | 3,613 | 2,129 | 362 |
| Other Income | -52,626 | -144,259 | -14,147 | -21,224 | -28,004 |
| Pre-tax Income | -62,731 | -157,248 | -21,227 | -22,521 | -22,098 |
| Income Tax | 58 | 145 | 42 | 100 | 94 |
| Net Income Continuous | -62,789 | -157,393 | -21,269 | -22,621 | -22,191 |
| Net Income | $-62,789 | $-157,393 | $-21,269 | $-22,621 | $-22,191 |
| EBITDA(a) | $-6,037 | $-7,913 | $-3,466 | $832 | $6,268 |